ArticleOpen forum infectious diseases2021

Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus.

Emma M Kileel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.